Translational Andrology and Urology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.9 | Q3 | 40.3% | 0.505 | Q2 | 61.3% |
| 2024 | 1.7 | Q3 | 41.8% | 0.671 | Q2 | 72.1% |
| 2023 | 1.9 | Q3 | 48.4% | 0.638 | Q2 | 72.8% |
| 2022 | 2.0 | Q3 | 48.8% | 0.603 | Q2 | 72.1% |
| 2021 | 2.5 | Q3 | 51.3% | 0.638 | Q2 | 74.7% |
| 2020 | — | — | 0.721 | Q2 | 76.9% | |
| 2019 | — | — | 0.737 | Q2 | 78.2% | |
| 2018 | — | — | 0.661 | Q2 | 73.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2223-4683
ISSN
2223-4691
country
HKcoverage
2012-2026